Background: Ascites and pleural effusion are well recognized complications of pancreatic diseases. Drug therapy of these is limited by high cost, prolonged hospitalization and failure rates ...

Ascites is the buildup of fluid in the abdominal cavity, which often develops as a complication of liver disease. However, ...

Malignant ascites can develop with late stage pancreatic cancer. Ascites involves the buildup of fluid in the abdomen. Doctors can drain the fluid to relieve symptoms, but fluid may return.

Sequana Medical NV has announced the US FDA approval of its Alfapump system for treating recurrent or refractory ascites due ...

Ascites is the most common complication of cirrhosis and a major cause of morbidity and hospitalization. Treatment of ascites is initially based on diuretics, but randomized studies assessing the ...

In contrast to LVP, which provides only symptomatic control and requires repeated procedures, TIPS efficiently prevents the formation of ascites and increases urinary sodium excretion by reducing ...

Many of us experience bloating from time to time, often the result of eating too much, but it can signal something far more ...

alfapump® is the first US approved active implantable medical device (Class III) for the treatment of recurrent or refractory ascites due to liver cirrhosis US market opportunity estimated at ...

The FDA has granted premarket approval to Sequana Medical’s alfapump implantable device for the treatment of recurrent or refractory ascites due to cirrhosis, according to a company press release.

Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis The Company will be hosting a further webcast with key opinion ...